TESARO Competitors and Similar CompaniesClear all
BeyondSpring's competitors and similar companies include Takeda and Oncoceutics.
 BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Oncoceutics Oncoceutics was a biotechnology company that developed small molecule compounds targeting G protein-coupled receptors for oncology applications. | |
Founding Date | Founding Date 2010 | Founding Date 1781 | Founding Date 2009 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Florham Park, US HQ | Locations Philadelphia, US HQ | |
Employees | Employees 4014% increase | Employees 47,4554% decrease | Employees 12 |
Valuation ($) | Valuation ($) 89.4 m | Valuation ($) 43.7 b | Valuation ($) N/A |
Financial | |||
Net income | Net income ($16.7m) (FY, 2024) | Net income ¥108.1b (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 2 (FY, 2019) | Phase I Trials Products 2 (May, 2025) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 1 (FY, 2017) | Phase II Trials Products 10 (May, 2025) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 3 (FY, 2019) | Phase III Trials Products 17 (May, 2025) | Phase III Trials Products N/A |
Funding | |||
Total funding raised | Total funding raised $ 36.1m | Total funding raised $ 57.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyOncoceutics
HQ
Philadelphia, US
Oncoceutics was a biotechnology company that developed small molecule compounds targeting G protein-coupled receptors for oncology applications.
View company